Moreover, Li et al. demonstrated that FGF14-AS2 inhibits prostate carcinoma cell growth by modulating the miR-96-5p/AJAP1 axis, indicating its tumor-suppressive role in prostate cancer [62]. Here, AJAP1 is linked to prostate carcinoma.